Extracorporeal membrane oxygenation versus cardiopulmonary bypass during transcatheter aortic valve implantation: a meta-analysis of survival benefits  

作　　者：Huiruo Liu Liangshan Wang Xing Hao Zhongtao Du Chenglong Li Hong Wang Xiaotong Hou 

机构地区：[1]Centre for Cardiac Intensive Care,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China

出　　处：《World Journal of Emergency Medicine》2024年第4期306-310,共5页世界急诊医学杂志（英文）

基　　金：supported by the Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support(ZYLX202111,to XTH);Beijing Hospitals Authority“Ascent Plan”(FDL20190601,to XTH);Young Elite Scientists Sponsorship Program by CAST(2022QNRC001,to LSW);National Natural Science Foundation of China(82200433,to LSW);Beijing Hospitals Authority Youth Programme(QML20230602,to LSW).

摘　　要：Since its approval by the Food and Drug Administration in 2011,transcatheter aortic valve implantation(TAVI)has rapidly evolved to become the preferred ultimate intervention for high-and intermediate-risk patients with severe symptomatic aortic stenosis.[1]This is due to its non-open-heart,minimally invasive and off-pump advantages.[1]Nevertheless,as a result of the frequent frailty and comorbidity profiles of patients undergoing TAVI,such as advanced cardiac dysfunction and extensive coronary artery disease,or technically difficult anatomy for the procedure itself,[2-4]it is common for these patients to experience critical circulatory collapse perioperatively.These factors are linked to elevated mortality rates,necessitating suitable mechanical circulatory support(MCS)to reverse the disastrous situations.[5]

关 键 词：ANATOMY BYPASS ELEVATED 

分 类 号：R654.2[医药卫生—外科学]